Concepedia

Days of Prophylactic Filgrastim Use to Reduce Febrile Neutropenia in Patients

Shane Scott, Bradley S. Stolshek, Moshe Fridman, David J. Delgado, Brian K. Link, Elizabeth A. Chrischilles

Journal of Managed Care Pharmacy · 2003 · 57 citations · 19 references

DOIFull text

Open access

Abstract

Primary prophylaxis with filgrastim (mainly Group 2) and secondary prophylaxis in Group 2 (mean 10.1 days) may be associated with a lower incidence of febrile neutropenia than secondary prophylaxis in Group 1.

References

19

A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation

Mary E. Charlson, Peter Pompei, Kathy L. Aleš et al. · Journal of Chronic Diseases · 1987 · 48.8K citations

, , +11

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases

Richard A. Deyo · Journal of Clinical Epidemiology · 1992 · 10.4K citations

, , +13

Report of the Committee on Hodgkin's Disease Staging Classification.

Paul P. Carbone, Henry S. Kaplan, K. Musshoff et al. · PubMed · 1971 · 4.2K citations

, , +6

Presentation adapting a clinical comorbidity index for use with ICD-9-CM administrative data: Differing perspectives

Patrick S. Romano, Leslíe L. Roos, James G. Jollis · Journal of Clinical Epidemiology · 1993 · 1.7K citations

, , +13

Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer

Jeffrey Crawford, Howard Ozer, Ronald G. Stoller et al. · New England Journal of Medicine · 1991 · 1.4K citations